Lilly stops promoting cancer drug after shock trial failureShares in Eli Lilly were down in early trading after the US drugmaker said its cancer drug Lartruvo Share XLilly stops promoting cancer drug after shock trial failurehttps://pharmaphorum.com/news/lilly-pulls-cancer-drug-from-market-after-shock-trial-failure/
FDA decisions could ‘slow to crawl’ because of government shutdownExperts have said the ongoing government shutdown may already have delayed approval and launch of new drugs, as Share XFDA decisions could ‘slow to crawl’ because of government shutdownhttps://pharmaphorum.com/news/fda-decisions-could-slow-to-crawl-because-of-government-shutdown/
FDA advisers divided on Sanofi’s oral type 1 diabetes drugThe future of Sanofi and Lexicon’s oral diabetes drug Zynquista hangs in the balance after an FDA advisory Share XFDA advisers divided on Sanofi’s oral type 1 diabetes drughttps://pharmaphorum.com/news/fda-divided-on-sanofis-oral-type-1-diabetes-drug/
Novartis and Oxford University begin R&D tie-upNovartis and Oxford University have begun a partnership that will attempt to use artificial intelligence to predict how Share XNovartis and Oxford University begin R&D tie-uphttps://pharmaphorum.com/news/novartis-and-oxford-university-begin-rd-tie-up/
J&J partners with Apple for ECG monitoring projectApple has a new big pharma partner to help put its new Apple Watch with built-in electrocardiogram (ECG) Share XJ&J partners with Apple for ECG monitoring projecthttps://pharmaphorum.com/news/jj-partners-with-apple-for-ecg-monitoring-project/
Communiqué Awards 2019 opens for healthcare comms entriesThe Communiqué Awards 2019 have launched, seeking entries in European, international and local healthcare communications. The UK-based med Share XCommuniqué Awards 2019 opens for healthcare comms entrieshttps://pharmaphorum.com/news/communique-awards-2019-launch/
Telehealth firm secures more cash to expand in China, Japan and USTelehealth firm Tyto Care has secured additional funding to help with the launch of its technology allowing for Share XTelehealth firm secures more cash to expand in China, Japan and UShttps://pharmaphorum.com/news/telehealth-firm-secures-more-cash-to-expand-in-china-japan-and-us/
FDA advisers back Amgen/UCB’s osteoporosis drug EvenityAmgen’s bone-building drug Evenity looks on course for US approval in certain women with osteoporosis after a panel Share XFDA advisers back Amgen/UCB’s osteoporosis drug Evenityhttps://pharmaphorum.com/news/fda-advisers-back-amgen-ucbs-osteoporosis-drug-evenity/
Lilly’s Verzenios approved by NICENICE has published draft guidance that now recommends Eli Lilly’s breast cancer drug Verzenios for use on the Share XLilly’s Verzenios approved by NICEhttps://pharmaphorum.com/news/lillys-verzenios-approved-nice/
